Cytopathology and Small Biopsy Update in the TMC at Houston Methodist Hospital

Saturday, March 3, 2018 | 7:00AM - 5:00PM Add to Calendar

Program Overview
Physicians need the most up-to-date knowledge and strategies in clinical pathology to provide the most appropriate ancillary testing and patient care. In order to address this need, this activity will provide the following:

  • Update on Thyroid Bethesda reporting with introduction of Non-invasive follicular variant of papillary carcinoma in 2016
  • Introduction and implementation of Paris system for urinary cytology reporting in 2016
  • Role of HPV testing in cervical cancer screening, current applications and future role in era of vaccination in different resource settings
  • HPV testing in head and neck cancer guidelines (2017 introduction)
  • Ancillary testing (Molecular and Immunohistochemistry) in cytology and small biopsy specimens
  • New Salivary gland cytology/microbiopsy reporting system introduced in 2017

Target Audience
This conference is designed for physicians, nurses, nurse practitioners, physician assistants, physical therapists, occupational therapists, speech-language pathologists, and residents/fellows in the neurological sciences.

Educational Objectives
At the conclusion of this activity, the participant should be able to:

  • Define Risk stratification based on cytology and HPV testing
  • Discuss Urinary cytology reporting terminology and Risk of malignancy associated with each
  • Comprehend the role of HPV testing in oropharyngeal cancers
  • Apply appropriate molecular testing for small specimens for management of lung cancers
  • Describe the diagnosis, molecular testing and management of thyroid nodules and how the new terminology (NIFTP) affects Risk of malignancy in reporting terminology

For more information and registration, visit:


Houston Methodist Research Institute

John F. Bookout Auditorium, 2nd Floor
6670 Bertner Ave.
Houston, Texas 77030


Houston Methodist CME